| |
| |
|
| Insider
Information: |
Hearne Michael S |
| Relationship: |
Chief Financial Officer |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
2,620 |
|
|
Indirect Shares
|
12,767,435 |
|
|
| Direct
Value |
$44,802,000 |
|
|
|
Indirect Value
|
$218,323,138,500 |
|
|
| Total
Shares |
12,770,055 |
|
|
| Total
Value |
$218,367,940,500 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
20
|
3
|
|
Stock
price went up :
|
10
|
0
|
| Stock
price went down : |
10
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
| Percentage
Gain/Loss : |
 -17.1%
|
-97.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Odonate Therapeutics Inc |
ODT |
Chief Financial Officer |
2021-03-15 |
2,620 |
2021-11-19 |
12,767,435 |
Premium* |
|
|
La Jolla Pharmaceutical Co |
LJPC |
Chief Financial Officer |
2022-08-22 |
0 |
2022-08-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
145 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2021-01-15 |
4 |
A |
$4.55 |
$618 |
D/D |
136 |
1,094 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2021-03-15 |
4 |
A |
$4.85 |
$616 |
D/D |
127 |
3,490 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2020-06-02 |
4 |
B |
$4.88 |
$1,237,060 |
I/I |
253,553 |
8,333,898 |
1.99 |
% |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2020-06-03 |
4 |
B |
$4.90 |
$714,783 |
I/I |
145,764 |
8,479,662 |
1.99 |
% |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2020-06-04 |
4 |
B |
$4.94 |
$1,065,636 |
I/I |
215,812 |
8,695,474 |
1.99 |
% |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2021-01-29 |
4 |
A |
$5.20 |
$614 |
D/D |
118 |
2,689 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2021-02-12 |
4 |
A |
$5.70 |
$3,051 |
D/D |
535 |
3,224 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2022-08-22 |
4 |
D |
$6.23 |
$63,459 |
D/D |
(10,186) |
0 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2022-08-22 |
4 |
D |
$6.23 |
$59,857,429 |
I/I |
(9,607,934) |
0 |
0 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-09-30 |
4 |
A |
$11.42 |
$571 |
D/D |
50 |
1,883 |
0 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-12-31 |
4 |
A |
$11.97 |
$539 |
D/D |
45 |
718 |
0 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-12-27 |
4 |
B |
$12.03 |
$120,315 |
I/I |
10,000 |
12,892,338 |
1.99 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-12-28 |
4 |
B |
$12.04 |
$253,863 |
I/I |
20,000 |
12,912,338 |
1.99 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-12-26 |
4 |
B |
$12.09 |
$368,287 |
I/I |
30,000 |
12,882,338 |
1.99 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-11-13 |
4 |
A |
$12.20 |
$561 |
D/D |
46 |
2,017 |
0 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-10-30 |
4 |
A |
$12.25 |
$564 |
D/D |
46 |
1,971 |
0 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-12-21 |
4 |
B |
$12.27 |
$255,828 |
I/I |
20,000 |
12,852,338 |
1.99 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-11-30 |
4 |
A |
$12.77 |
$575 |
D/D |
45 |
2,062 |
0 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-12-14 |
4 |
A |
$12.85 |
$540 |
D/D |
42 |
673 |
0 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-12-15 |
4 |
A |
$12.91 |
$555 |
D/D |
43 |
2,105 |
0 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-09-15 |
4 |
A |
$13.06 |
$562 |
D/D |
43 |
1,833 |
0 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-09-28 |
4 |
B |
$13.06 |
$1,305,710 |
I/I |
100,000 |
15,227,900 |
1.99 |
% |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-12-20 |
4 |
B |
$13.17 |
$131,742 |
I/I |
10,000 |
12,832,338 |
1.99 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-10-15 |
4 |
A |
$13.35 |
$561 |
D/D |
42 |
1,925 |
0 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-11-30 |
4 |
A |
$13.40 |
$536 |
D/D |
40 |
631 |
0 |
- |
|
145 Records found
|
|
Page 3 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
